Monte Rosa Therapeutics, Inc.

GLUE·NASDAQ·$19.20Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/07/26 10-KFY 202503/17/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report10/01/26 8-KCurrent report09/08/26 8-KCurrent report08/06/26 8-KCurrent report06/11/26 8-KCurrent report05/07/26

Prospectuses and Registrations

S-8Registration of securities for employees03/17/26 S-3ASRAutomatic shelf registration02/11/26 424B5Prospectus supplement01/09/26 424B5Prospectus supplement01/07/26 S-3Shelf registration03/20/25

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/25/25 DEFA14AAdditional proxy materials04/25/25 DEF 14ADefinitive proxy04/26/24

Ownership

Form 4Insider transaction10/06/26 SC 13GBeneficial ownership08/14/26 SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/17/26 144Proposed sale of securities07/16/26

Other

ARSAnnual report to shareholders04/29/26 UPLOADLetter from the SEC08/21/25 CORRESPCorrespondence with the SEC07/22/25 UPLOADLetter from the SEC07/15/25 ARSAnnual report to shareholders04/25/25